Table 3.
Participant willingness to receive, purchase, or recommend COVID-19 vaccine.
|
Variable (n, %) |
Total (N = 2,925) |
Jordan (n = 868) |
Lebanon (n = 632) |
KSA (n = 592) |
Iraq (n = 833) |
P-value1 |
|---|---|---|---|---|---|---|
| Willingness to receive a COVID-19 vaccine | ||||||
| Acceptors Hesitant Rejecters |
728 (24.9) 955 (32.6) 1,242 (42.5) |
148 (17.1) 247 (28.5) 473 (54.5) |
117 (18.5) 220 (34.8) 295 (46.7) |
174 (29.4) 199 (33.6) 219 (37.0) |
289 (34.7) 289 (34.7) 255 (30.6) |
< 0.001 |
| Willingness to purchase the vaccine if the cost is not covered by the government2 | ||||||
| Acceptors Hesitant Rejectors |
438 (60.2) 125 (25.0) 108 (14.8) |
100 (76.6) 30 (20.3) 18 (12.2) |
69 (59.0) 39 (33.3) 9 (7.7) |
103 (59.2) 40 (23.0) 31 (17.8) |
166 (57.4) 73 (25.3) 50 (17.3) |
0.035 |
| Willingness to advise relatives and friends at risk of infection to get vaccinated | ||||||
| Acceptors Hesitant Rejectors |
943 (32.2) 985 (33.7) 997 (34.1) |
209 (24.1) 261 (30.1) 398 (45.9) |
162 (25.6) 228 (36.1) 242 (38.3) |
220 (37.2) 205 (34.6) 167 (28.2) |
352 (42.3) 291 (34.9) 190 (22.8) |
< 0.001 |
KSA, Kingdom of Saudi Arabia.
1
Calculated using Pearson Chi square test.
2
Percentage calculated for subjects who were willing to take the vaccines (n = 728).